Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function.

Ma F, Zhang J, Wang H, Wu Y, Wu Y

Open source

DOI
10.1155/2022/4829750
Published
2022
Container
Disease markers
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/4829750,
  title = {Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function.},
  author = {Ma F and Zhang J and Wang H and Wu Y and Wu Y},
  year = {2022},
  journal = {Disease markers},
  doi = {10.1155/2022/4829750},
  url = {https://doi.org/10.1155/2022/4829750}
}

RIS

TY  - JOUR
TI  - Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function.
AU  - Ma F
AU  - Zhang J
AU  - Wang H
AU  - Wu Y
AU  - Wu Y
PY  - 2022
JO  - Disease markers
DO  - 10.1155/2022/4829750
UR  - https://doi.org/10.1155/2022/4829750
ER  - 

APA

F, M., J, Z., H, W., Y, W., & Y, W. (2022). Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function.. Disease markers. https://doi.org/10.1155/2022/4829750

Source records